Literature DB >> 8804499

Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells.

K Tatsutani1, B Rubinsky, G Onik, R Dahiya.   

Abstract

OBJECTIVES: Recent advances in imaging technology and cryotechnology have rekindled interest in prostate cryosurgery. Cryosurgery, however, cannot be applied precisely without knowing how the thermal variables used during the procedure affect tissue destruction. The goal of this article is to provide quantitative values for the relationship between thermal variables during freezing and the destruction of human primary prostatic adenocarcinoma cells.
METHODS: Human primary prostatic adenocarcinoma cells were frozen with controlled thermal parameters, using a directional solidification apparatus. Cell viability was determined after thawing, using trypan blue and a two-dye fluorescent test and correlated to the thermal variables used during freezing.
RESULTS: Human primary prostatic adenocarcinoma cells are damaged by intracellular chemical damage when frozen with cooling rates lower than 5 degrees C/min and by intracellular ice formation when frozen with cooling rates higher than 25 degrees C/min. A double freeze/thaw cycle is required to ensure complete cell destruction at high subzero temperatures, which must be lower than -40 degrees C for the low cooling rates and lower than -19 degrees C for the higher cooling rate.
CONCLUSIONS: Haphazard freezing does not necessarily destroy tissue during cryosurgery; however, quantitative data on the relation between thermal variables and frozen cell destruction can provide the means for performing cryosurgery more precisely and with greater control over the outcome of the procedure.

Entities:  

Mesh:

Year:  1996        PMID: 8804499     DOI: 10.1016/S0090-4295(96)00199-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  16 in total

Review 1.  Principles of low temperature cell preservation.

Authors:  Boris Rubinsky
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

2.  Cancer cryotherapy: evolution and biology.

Authors:  Dan Theodorescu
Journal:  Rev Urol       Date:  2004

Review 3.  Cryotherapy.

Authors:  Katsuto Shinohara
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

Review 4.  [Cryoablation of localized prostate cancer. Current state].

Authors:  U K F Witzsch; E Becht
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

5.  Multipoint Thermal Sensors Associated with Improved Oncologic Outcomes Following Cryoablation.

Authors:  Jeremy W Martin; Roshan M Patel; Zhamshid Okhunov; Aashay Vyas; Duane Vajgrt; Ralph V Clayman
Journal:  J Endourol       Date:  2017-02-17       Impact factor: 2.942

6.  [Cryoablation of prostate cancer].

Authors:  U K F Witzsch; E Becht
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

Review 7.  [Focal prostate cancer therapy: capabilities, limitations and prospects].

Authors:  D Baumunk; A Blana; R Ganzer; T Henkel; J Köllermann; A Roosen; S Machtens; G Salomon; L Sentker; U Witzsch; K U Köhrmann; M Schostak
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

8.  [Cryoablation of prostate cancer].

Authors:  U K F Witzsch; K Skriapas; E Becht
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

Review 9.  "Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer.

Authors:  Jonathan B Bloom; Samuel A Gold; Graham R Hale; Kareem N Rayn; Vikram K Sabarwal; Ivane Bakhutashvili; Vladimir Valera; Baris Turkbey; Peter A Pinto; Bradford J Wood
Journal:  Gland Surg       Date:  2018-04

10.  MRI-guided cryoablation: In vivo assessment of focal canine prostate cryolesions.

Authors:  Sonal Josan; Donna M Bouley; Maurice van den Bosch; Bruce L Daniel; Kim Butts Pauly
Journal:  J Magn Reson Imaging       Date:  2009-07       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.